CoChat

Certain Endocrine and Metabolic Facets of the Steroid Withdrawal Syndrome

AMATRUDA, THOMAS T., HURST, AMATRUDA M., D'ESOPO, NICHOLAS D. · 1965 · The Journal of Clinical Endocrinology & Metabolism
Cited by 83

The DOI matches its Crossref record.

Abstract

Clinical features of Cushing's syndrome developed in 22 male patients with pulmonary tuberculosis who received prednisone, 30 mg daily, and zinc corticotropin (ACTH), 40 U every other day, for 3 months in addition to antituberculous chemotherapy. The prednisone was tapered during an additional 3-week period and the zinc ACTH was continued throughout the tapering period for an additional 4 days. Following discontinuation of prednisone-ACTH therapy, the patients developed features of the steroid withdrawal syndrome—anorexia, nausea, lethargy, arthralgia, weakness, desquamation and weight loss. The integrity of the hypothalamic-pituitary-adrenal system was evaluated in 13 patients while steroid withdrawal symptoms were present, and in randomly chosen controls with tuberculosis by measuring the response of plasma and urine steroids to the administration of methopyrapone (Su-4885) and to exogenous ACTH. The base line levels of plasma and urine steroids and response to ACTH were similar in the steroid-ACTH withdrawal and control groups. The steroid-ACTH withdrawal patients exhibited a definite but diminished response to methopyrapone compared to the controls. However, there was no correlation between the intensity or duration of steroid withdrawal symptoms and the response to methopyrapone. Furthermore, in 9 steroid-ACTH withdrawal patients serial measurements of urine and plasma steroids revealed normal levels while symptoms were present, and there was no correlation between the degree of symptomatology and the steroid level in the same patient or among different patients. In 5 patients the response to methopyrapone had returned to normal when they were retested 3 weeks to 6 months after the initial study. Six steroid withdrawal patients subsequently tolerated major pulmonary surgery without steroid coverage, and their levels of plasma 17-hydroxycorticoids pre- and postoperatively did not differ from those of controls undergoing similar surgery. Since the steroid withdrawal syndrome could not be ascribed to either hypoadrenocorticism or hypoadrenocorticotropism, the possibilities of hypervitaminosis A, hypercalcemia, pancreatitis and pseudotumor cerebri were considered and excluded. The etiology and pathogenesis of the steroid withdrawal syndrome in these patients and in other clinical and experimental situations remain obscure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jcem-25-9-1207

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 83

Metadata

Authors
AMATRUDA, T. T., HURST, A. M., & D'ESOPO, N. D.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
1965-09
Volume
25
Issue
9
Pages
1207-1217
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2094359164
Cited by
83
References
0
FWCI
1.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Certain Endocrine and Metabolic Facets of the Steroid Withdrawal Syndrome. https://app.cochat.ai/papers/10.1210/jcem-25-9-1207
The paper
AMATRUDA, T. T., HURST, A. M., & D'ESOPO, N. D. (1965). Certain Endocrine and Metabolic Facets of the Steroid Withdrawal Syndrome. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-25-9-1207

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.